NIH-funded research R01 grant

Remote monitoring and nurse follow-up to manage chemotherapy-induced peripheral neuropathy

Official title: Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy

Funded at University of Vermont & St Agric College · NIH-11328854 · Data updated 2026-11-12

A program uses symptom reporting tools with nurse follow-up to reduce and better manage chemotherapy-induced neuropathy for cancer survivors, during and after treatment.

More Chemotherapy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Vermont & St Agric College
NIH-funded
Lab location1 site (Burlington, United States)
Project startMay 6, 2021
Project endApril 30, 2027
Funding year2026
Award (this year)$372,282
NIH project number5R01CA247517-06
Project IDNIH-11328854 on NIH RePORTER

Who could benefit from this research

Could help

Adults with cancer who have or are experiencing chemotherapy-induced peripheral neuropathy and can use phone, app, or web-based reporting.

Less likely to help

Patients without CIPN or those unable to use digital symptom reporting tools may see little to no benefit.

What this research studies

This project tests a care model called Symptom Care at Home with NP follow up (SCH-NP) to help people experiencing CIPN during the most painful and disabling times. Patients would report CIPN symptoms via phone, app, or web, and receive proactive nurse practitioner follow-up and a standardized guideline-based care plan. The study will compare SCH-NP to usual care over 12 weeks after chemotherapy to see if CIPN symptoms improve and overall quality of life improves. The goal is to show that proactive, guideline-driven symptom management can reduce CIPN burden and healthcare needs for cancer survivors.

Why it matters

Potential benefit: If successful, patients could experience less CIPN pain and disability and better quality of life during and after chemotherapy.

How similar studies have gone: Prior work showed that symptom reporting with nurse follow-up reduced CIPN symptoms during chemotherapy; this study extends to the post-chemotherapy period with maximal symptoms.

Where this research is happening

  • University of Vermont & St Agric College
    Burlington, United States
    Active

Researchers

  • Principal investigator: Kolb, Noah Allan — University of Vermont & St Agric College
  • Study coordinator: Kolb, Noah Allan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.